Assessment of prophylactic antibiotics administration for acute pancreatitis: a meta-analysis of randomized controlled trials
- PMID: 31929369
- PMCID: PMC7028185
- DOI: 10.1097/CM9.0000000000000603
Assessment of prophylactic antibiotics administration for acute pancreatitis: a meta-analysis of randomized controlled trials
Abstract
Background: Recent evidence has shown that prophylactic antibiotic treatment in patients with acute pancreatitis is not associated with a significant decrease in mortality or morbidity. The use and efficacy of prophylactic antibiotic treatment in acute pancreatitis remain controversial. This meta-analysis was conducted to assess whether antibiotic prophylaxis is beneficial in patients with acute pancreatitis.
Methods: We searched randomized controlled trials (RCTs) of prophylactic use of antibiotics using Medline (PubMed), Embase, the Cochrane Library, and Web of Science. The data were analyzed using Review Manager 5.3 software. We performed pooled analyses for infected pancreatic necrosis, mortality, surgical intervention, and non-pancreatic infection. Odds ratios (ORs) from each trial were pooled using a random or fixed effects model, depending on the heterogeneity of the included studies. Sub-group analysis or sensitivity analysis was conducted to explore potential sources of heterogeneity, when necessary.
Results: Totally, 11 RCTs involving 747 participants were included, with an intervention group (prophylactic use of antibiotics, n = 376) and control group (n = 371). No significant differences were found regarding antibiotic prophylaxis with respect to incidence of infected pancreatic necrosis (OR, 0.74; 95% confidence interval [CI], 0.50-1.09; P = 0.13), surgical intervention (OR, 0.92; 95% CI, 0.62-1.38; P = 0.70), and morality (OR, 0.71; 95% CI, 0.44-1.15; P = 0.16). However, antibiotic prophylaxis was associated with a statistically significant reduction in the incidence of non-pancreatic infection (OR, 0.59; 95% CI, 0.42-0.84; P = 0.004).
Conclusions: Prophylactic antibiotics can reduce the incidence of non-pancreatic infection in patients with AP.
Conflict of interest statement
None.
Figures













Similar articles
-
Assessment of Prophylactic Carbapenem Antibiotics Administration for Severe Acute Pancreatitis: An Updated Systematic Review and Meta-Analysis.Digestion. 2022;103(3):183-191. doi: 10.1159/000520892. Epub 2022 Jan 13. Digestion. 2022. PMID: 35026770
-
Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials.Am J Gastroenterol. 2008 Jan;103(1):104-10. doi: 10.1111/j.1572-0241.2007.01575.x. Epub 2007 Oct 9. Am J Gastroenterol. 2008. PMID: 17925000 Review.
-
Prophylactic antibiotic treatment in acute necrotizing pancreatitis: results from a meta-analysis.Scand J Gastroenterol. 2008;43(10):1249-58. doi: 10.1080/00365520802130175. Scand J Gastroenterol. 2008. PMID: 18609129
-
Role of prophylactic antibiotic administration in severe acute pancreatitis: a meta-analysis.Med Princ Pract. 2006;15(2):106-10. doi: 10.1159/000090913. Med Princ Pract. 2006. PMID: 16484836
-
Prophylactic antibiotics reduce pancreatic necrosis in acute necrotizing pancreatitis: a meta-analysis of randomized trials.Dig Surg. 2010;27(6):442-9. doi: 10.1159/000318780. Epub 2010 Nov 11. Dig Surg. 2010. PMID: 21071945
Cited by
-
Exploring the Microbial Landscape: Gut Dysbiosis and Therapeutic Strategies in Pancreatitis-A Narrative Review.Biomedicines. 2024 Mar 14;12(3):645. doi: 10.3390/biomedicines12030645. Biomedicines. 2024. PMID: 38540258 Free PMC article. Review.
-
Appropriate Use of Antibiotics in Acute Pancreatitis: A Scoping Review.Antibiotics (Basel). 2024 Sep 18;13(9):894. doi: 10.3390/antibiotics13090894. Antibiotics (Basel). 2024. PMID: 39335067 Free PMC article.
-
Clinical Practice Guideline—Acute and Chronic Pancreatitis.Dtsch Arztebl Int. 2022 Jul 25;119(29-30):495-501. doi: 10.3238/arztebl.m2022.0223. Dtsch Arztebl Int. 2022. PMID: 35945698 Free PMC article.
-
The composition of the stent microbiome is associated with morbidity and adverse events during endoscopic drainage therapy of pancreatic necroses and pseudocysts.Front Med (Lausanne). 2024 Sep 16;11:1462122. doi: 10.3389/fmed.2024.1462122. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39351008 Free PMC article.
-
Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report.Turk J Gastroenterol. 2024 Nov 11;35(Suppl 1):S1-S44. doi: 10.5152/tjg.2024.24392. Turk J Gastroenterol. 2024. PMID: 39599919 Free PMC article. Review.
References
-
- Vege SS, Gardner TB, Chari ST, Munukuti P, Pearson RK, Clain JE, et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include “moderately severe acute pancreatitis”. Am J Gastroenterol 2009; 104:710–715. doi: 10.1038/ajg.2008.77. - PubMed
-
- Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102–111. doi: 10.1136/gutjnl-2012-302779. - PubMed
-
- Koutroumpakis E, Slivka A, Furlan A, Dasyam AK, Dudekula A, Greer JB, et al. Management and outcomes of acute pancreatitis patients over the last decade: a US tertiary-center experience. Pancreatology 2017; 17:32–40. doi: 10.1016/j.pan.2016.10.011. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical